Cannabis Control Bill Moves Forward: Medical Use Takes Center Stage

Background: From Decriminalization to a Dedicated Regulatory Framework

The Cabinet has approved the draft Cannabis Control Act (the “Cannabis Control Bill”), marking another significant step toward establishing a dedicated statutory framework for cannabis following its removal from the narcotics list. The Bill is intended to address regulatory gaps that have existed while cannabis has largely been regulated through the existing framework for controlled herbs and subordinate legislation. The Ministry of Public Health has emphasized that the central policy underlying the Bill is the use of cannabis for medical and health purposes rather than recreational consumption. Before submission to the Cabinet, the responsible authorities conducted regulatory impact assessments and several rounds of public consultation.

What the Bill Would Regulate:

The Bill would introduce an integrated regulatory system covering the cannabis supply chain. According to information released by the Ministry of Public Health, it provides for a national cannabis committee and licensing requirements for activities including cultivation, production, importation, exportation, and sale. The framework is intended to make cultivation sources traceable and to provide clearer controls over cannabis flowers and other regulated activities. It also includes protections for children, young persons, pregnant women and other vulnerable groups, restrictions on advertising and marketing of cannabis flowers and smoking equipment, and clearer penalties for violations. The proposed framework distinguishes legitimate medical treatment and research from recreational use, with recreational consumption subject to regulatory restrictions and penalties.

Cabinet Approval Does Not Mean the Bill Is Yet Law:

Cabinet approval is only one stage of the legislative process. The Cannabis Control Bill must next be submitted to the House of Representatives, where legislation is considered in three readings. If approved, it proceeds to the Senate. Depending on whether the Senate approves, rejects or amends the Bill, further parliamentary procedures may be required. Once the Bill has obtained parliamentary approval, it proceeds through the constitutional process for royal assent and publication in the Royal Gazette. It will become legally effective in accordance with the commencement provision in the enacted legislation. The provisions described above therefore remain subject to amendment during parliamentary consideration.

Tighter Controls Are Already in Force:

The proposed Act should also be distinguished from regulatory changes that are already in force. Existing ministerial regulations have tightened the rules applicable to cannabis flowers and are expressly intended to restrict their use to medical purposes. Under the current framework, existing licensees may generally continue operating until their licenses expire, but businesses seeking to continue thereafter must satisfy the applicable requirements under the new licensing regime. Guidance issued by the Department of Thai Traditional and Alternative Medicine indicates that the medical cannabis framework is centered on specified categories of licensed establishments and the involvement of authorized healthcare professionals. Cannabis businesses should therefore not wait for the Cannabis Control Bill to become law before reviewing their operating models, licenses, sourcing arrangements, premises, and professional-supervision requirements.

Key Takeaways:

• Cabinet approval is an important legislative milestone, but the Cannabis Control Bill is not yet effective law and remains subject to parliamentary consideration and possible amendment.
• The proposed framework focuses on medical and health use rather than recreational use, with regulatory controls extending across the cannabis supply chain.
• Licensing, traceability, advertising restrictions, protection of vulnerable groups, and stronger enforcement mechanisms are central features of the proposed regime.
• A tighter medical-use regime for cannabis flowers is already operating under existing subordinate legislation, independently of the pending Bill.
• Existing cannabis businesses should review their current licenses and assess whether their operations will satisfy the applicable medical-use regulatory requirements when renewal or a new license becomes necessary.

Author: Panisa Suwanmatajarn, Managing Partner.

Other Articles

• DIP e-Exchange: A New Framework for Accessing and Using IP Data
• When Health Data Moves Beyond Its Original Purpose
• Criteria and Conditions for Allowing Foreign Nationals to Use Automated Passport Control Channels
• Substantive Agreement Reached on the Thailand–United States Agreement on Reciprocal Trade (ART)
• Social Media Advertising: New Advertiser Verification Requirements Take Effect Soon
• Thailand Revises Visa Exemption Scheme: 30-Day Stay and Revised List of Eligible Countries